Cancer Study Links COVID Shots to Longer Survival

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — BERLIN — Non-small cell lung cancer (NSCLC) patients starting immunotherapy were almost twice as likely to be alive 3 years later if they received a COVID-19 vaccine at the time of treatment, a researcher reported here. Retrospective…




